Abstract:PURPOSE: To assess the efficacy and safety of repeated low-level red-light (RLRL) therapy in myopia control in children.DESIGN: Multicenter, randomized, parallel-group, single-blind clinical trial.PARTICIPANTS: Two hundred sixty-four eligible children 8 to 13 years of age with myopia of cycloplegic spherical equivalent refraction (SER) of -1.00 to -5.00 diopters (D), astigmatism of 2.50 D or less, anisometropia of 1.50 D or less, and best-corrected visual acuity (BCVA) of 0.0 logarithm of the minimum angle of resolution or more were enrolled in July and August 2019. Follow-up was completed in September 2020.METHODS: Children were assigned randomly to the intervention group (RLRL treatment plus single-vision spectacle [SVS]) and the control group (SVS). The RLRL treatment was provided by a desktop light therapy device that emits red light of 650-nm wavelength at an illuminance level of approximately 1600 lux and a power of 0.29 mW for a 4-mm pupil (class I classification) and was administered at home under supervision of parents for 3 minutes per session, twice daily with a minimum interval of 4 hours, 5 days per week.MAIN OUTCOME MEASURES: The primary outcome and a key secondary outcome were changes in axial length and SER measured at baseline and the 1-, 3-, 6-, and 12-month follow-up visits. Participants who had at least 1 postrandomization follow-up visit were analyzed for treatment efficacy based on a longitudinal mixed model.RESULTS: Among 264 randomized participants, 246 children (93.2%) were included in the analysis (117 in the RLRL group and 129 in the SVS group). Adjusted 12-month axial elongation and SER progression were 0.13 mm (95% confidence interval [CI], 0.09-0.17mm) and -0.20 D (95% CI, -0.29 to -0.11D) for RLRL treatment and 0.38 mm (95% CI, 0.34-0.42 mm) and -0.79 D (95% CI, -0.88 to -0.69 D) for SVS treatment. The differences in axial elongation and SER progression were 0.26 mm (95% CI, 0.20-0.31 mm) and -0.59D (95% CI, -0.72 to -0.46 D) between the RLRL and SVS groups. No severe adverse events (sudden vision loss ≥2 lines or scotoma), functional visual loss indicated by BCVA, or structural damage seen on OCT scans were observed.CONCLUSIONS: Repeated low-level red-light therapy is a promising alternative treatment for myopia control in children with good user acceptability and no documented functional or structural damage.

Modified Posterior Scleral Reinforcement As a Treatment for High Myopia in Children and Its Therapeutic Effect

The effectiveness and safety of modified posterior scleral reinforcement in Chinese children with high myopia

The efficacy of modified posterior scleral reinforcement with round scleral patches in Chinese children with high myopia

Efficacy of Posterior Scleral Reinforcement in Treating Anisometropic Amblyopia Associated With Unilateral High Myopia in Children

Clinical outcomes of posterior scleral reinforcement in Chinese high myopia children

Effects of posterior scleral reinforcement in pathological myopia: a 3-year follow-up study

Posterior scleral reinforcement for the treatment of myopic traction maculopathy

[Long-Term Studies on Clinical Therapeutic Efficiency of Posterior Scleral Reinforcement Surgery].

The Efficacy and Safety of Modified Snyder–Thompson Posterior Scleral Reinforcement in Extensive High Myopia of Chinese Children

Posterior Scleral Reinforcement Combined with Patching Therapy for Pre-School Children with Unilateral High Myopia

Posterior scleral reinforcement on progressive high myopic young patients

Genipin-Crosslinked Donor Sclera for Posterior Scleral Contraction/Reinforcement to Fight Progressive Myopia.

Investigation of Macular Choroidal Thickness and Blood Flow Change by Optical Coherence Tomography Angiography After Posterior Scleral Reinforcement

Axial Shortening Effects of Repeated Low-level Red-light Therapy in Children with High Myopia: A Multicenter Randomized Controlled Trial

Posterior Chamber Phakic Intraocular Lens Implantation for High Myopia

Author Correction: Synergistic Effects of Defocus-Incorporated Multiple Segments and Atropine in Slowing the Progression of Myopia

Effect and safety posterior scleral reinforcement on controlling myopia in children: a meta-analysis

Analysis of morphological and quantitative changes in pathological myopia and perioperative changes in posterior scleral reinforcement using three-dimensional magnet resonance imaging

Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children

The effect of individualized ocular refraction customized spectacle lenses on myopia control in schoolchildren: A 1-year randomised clinical trial

Three optical intervention methods for low myopia control in children: a one-year follow-up study